Cardiol Therapeutics Dirección
Dirección controles de criterios 1/4
El CEO de Cardiol Therapeutics' es David Elsley , nombrado en Jan 2017, tiene una permanencia de 7.42 años. compensación anual total es CA$748.10K, compuesta por 70.2% salario y 29.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.69% de las acciones de la empresa, por valor de CA$3.43M. La antigüedad media del equipo directivo y de la junta directiva es de 4.7 años y 2.4 años, respectivamente.
Información clave
David Elsley
Chief Executive Officer (CEO)
CA$748.1k
Compensación total
| Porcentaje del salario del CEO | 70.2% |
| Permanencia del CEO | 7.5yrs |
| Participación del CEO | 1.8% |
| Permanencia media de la dirección | 4.8yrs |
| Promedio de permanencia en la Junta Directiva | 2.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Deliver On Growth Plans?
May 01
Will Cardiol Therapeutics (TSE:CRDL) Spend Its Cash Wisely?
Jan 06Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?
Sep 13We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully
May 24We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth
Jan 20We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth
Aug 10We're Not Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn
Apr 17Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation
Dec 09We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully
Aug 19Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation
Apr 18Companies Like Cardiol Therapeutics (TSE:CRDL) Are In A Position To Invest In Growth
Jan 03Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -CA$30m |
| Dec 31 2023 | CA$748k | CA$525k | -CA$28m |
| Sep 30 2023 | n/a | n/a | -CA$28m |
| Jun 30 2023 | n/a | n/a | -CA$30m |
| Mar 31 2023 | n/a | n/a | -CA$29m |
| Dec 31 2022 | CA$654k | CA$525k | -CA$31m |
| Sep 30 2022 | n/a | n/a | -CA$30m |
| Jun 30 2022 | n/a | n/a | -CA$32m |
| Mar 31 2022 | n/a | n/a | -CA$32m |
| Dec 31 2021 | CA$1m | CA$455k | -CA$32m |
| Sep 30 2021 | n/a | n/a | -CA$35m |
| Jun 30 2021 | n/a | n/a | -CA$30m |
| Mar 31 2021 | n/a | n/a | -CA$27m |
| Dec 31 2020 | CA$517k | CA$450k | -CA$21m |
| Sep 30 2020 | n/a | n/a | -CA$14m |
| Jun 30 2020 | n/a | n/a | -CA$13m |
| Mar 31 2020 | n/a | n/a | -CA$13m |
| Dec 31 2019 | CA$450k | CA$450k | -CA$14m |
| Sep 30 2019 | n/a | n/a | -CA$20m |
| Jun 30 2019 | n/a | n/a | -CA$21m |
| Mar 31 2019 | n/a | n/a | -CA$19m |
| Dec 31 2018 | CA$713k | CA$363k | -CA$16m |
Compensación vs. Mercado: La compensación total de David($USD545.35K) está por encima de la media de empresas de tamaño similar en el mercado Canadian ($USD175.38K).
Compensación vs. Ingresos: La compensación de David ha aumentado mientras la empresa no es rentable.
CEO
David Elsley
7.5yrs
Permanencia
CA$748,100
Compensación
Mr. David G. Elsley, MBA, has been the President, Chief Executive Officer and Director of Cardiol Therapeutics Inc since January 19, 2017. Mr. Elsley is a business leader with a proven track record of deve...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.5yrs | CA$748.10k | 1.76% CA$ 3.3m | |
| CFO, Corporate Secretary & Director | 5.9yrs | CA$294.80k | 0.16% CA$ 297.0k | |
| Chief Operating Officer | 3.6yrs | CA$515.90k | 0.044% CA$ 81.0k | |
| Chief Medical Officer & Head of Research & Development | 3.3yrs | CA$746.56k | 0.35% CA$ 646.3k | |
| Investor Relations | no data | sin datos | sin datos |
4.8yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de CRDL se considera experimentado (4.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.5yrs | CA$748.10k | 1.76% CA$ 3.3m | |
| CFO, Corporate Secretary & Director | 2.2yrs | CA$294.80k | 0.16% CA$ 297.0k | |
| Independent Director | 4.6yrs | CA$60.00k | 0.21% CA$ 384.7k | |
| Independent Director | 2.3yrs | CA$76.92k | 0% CA$ 0 | |
| Independent Director | 6.6yrs | CA$58.00k | 0.68% CA$ 1.3m | |
| Independent Director | 2.8yrs | CA$71.52k | 1.13% CA$ 2.1m | |
| Member of Scientific Advisory Board | 2.5yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.5yrs | sin datos | sin datos | |
| Independent Director | 2.2yrs | CA$82.32k | 0.088% CA$ 162.0k | |
| Independent Chairman | 5.9yrs | CA$112.68k | 0.22% CA$ 411.4k | |
| Member of Scientific Advisory Board | 2.5yrs | sin datos | sin datos |
2.5yrs
Permanencia media
56yo
Promedio de edad
Junta con experiencia: La junta directiva de CRDL no se considera experimentada (2.3 años de permanencia promedio), lo que sugiere una nueva junta directiva.